FDA Inspection 801477 — Irenda Corporation

Irenda Corporation — FEI 2050154

The FDA completed an inspection of Irenda Corporation on September 17, 2012 in Los Angeles, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 21 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 17, 2012
Fiscal Year
2012
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
1543721 CFR 111.15(a)(1)Grounds - equipment, litter, weeds
1544321 CFR 111.15(b)(2)Physical plant - repair
1553221 CFR 111.255(b)Batch record - complete
1562421 CFR 111.180(b)(3)Documentation - components
1564521 CFR 111.455(c)Hold - mix-up, contamination, deterioration
1566521 CFR 111.303Written procedures - tests, examinations; specifications met
1585821 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
1586121 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
1587021 CFR 111.75(c)(1)Specifications met - verify; production, process control
1593521 CFR 111.105(d)Quality control - basis; tests, examinations
188521 CFR 211.165(b)Microbiological testing
191221 CFR 211.166(a)Written program not followed
203121 CFR 211.194(a)Complete test data included in records
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
360321 CFR 211.160(b)Scientifically sound laboratory controls
361021 CFR 211.160(b)(3)Drug product sample
439121 CFR 211.180(e)(2)Items to cover on annual reviews
441821 CFR 211.42(b)Adequate space lacking to prevent mix-ups and contamination